Coronavirus Update: Regeneron Gets Warp Speed Funding, Conflict Slowing Moderna's Progress
Plus: GSK agrees new vaccine collaboration
Operation Warp Speed extends its funding beyond vaccines into antibodies, while insiders say friction between Moderna and US government scientists has caused delays.